Discontinued — last reported Q1 '24
Labcorp Holdings 2031 increased by 4.7% to $258.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.5%, from $232.10M to $258.70M. This increase may warrant attention — for this metric, lower values are generally preferred.
Lower projected expenses in later years indicate the eventual expiration of amortization schedules for older acquisitions.
This represents the projected amortization expense for finite-lived intangible assets for the year 2031. It is part of t...
Standard disclosure for banks with significant historical acquisition activity.
other_finite_lived_intangible_assets_amortization_expens_5777a7| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $200.40M | $201.20M | $233.30M | $229.10M | $234.50M | $233.90M | $181.10M | $198.10M | $209.00M | $209.10M | $232.20M | $232.10M | $234.70M | $247.20M | $258.70M |
| QoQ Change | — | +0.4% | +16.0% | -1.8% | +2.4% | -0.3% | -22.6% | +9.4% | +5.5% | +0.0% | +11.0% | -0.0% | +1.1% | +5.3% | +4.7% |
| YoY Change | — | — | — | +14.3% | +16.6% | +0.3% | -21.0% | -15.5% | -10.6% | +15.5% | +17.2% | +11.1% | +12.2% | +6.5% | +11.5% |